EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Scope & Guideline

Fostering Excellence in Nuclear Medicine Research

Introduction

Welcome to the EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1619-7070
PublisherSPRINGER
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1996 to 1997, 1999, from 2001 to 2024
AbbreviationEUR J NUCL MED MOL I / Eur. J. Nucl. Med. Mol. Imaging
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The European Journal of Nuclear Medicine and Molecular Imaging focuses on advancing the field of nuclear medicine through the publication of high-quality research articles that explore the application of molecular imaging and radiopharmaceutical therapies in clinical practice. This journal serves as a platform for disseminating cutting-edge developments in imaging technologies, therapeutic applications, and innovative methodologies.
  1. Theranostics in Cancer Treatment:
    The journal emphasizes the integration of diagnostics and therapeutics, particularly in oncology, highlighting studies on radioligand therapy and personalized treatment strategies for various cancers.
  2. Advancements in Molecular Imaging Techniques:
    It covers innovative imaging methods, including PET, SPECT, and hybrid imaging modalities, showcasing the latest technological advancements and their clinical implications.
  3. Radiopharmaceutical Development and Application:
    The journal includes research on the synthesis, characterization, and clinical application of new radiopharmaceuticals, focusing on their efficacy and safety in diagnostics and therapy.
  4. Clinical Applications and Guidelines:
    It provides insights into clinical practices, including guidelines for the use of imaging in various medical conditions, and explores the role of molecular imaging in treatment decision-making.
  5. Artificial Intelligence and Machine Learning in Imaging:
    The journal discusses the integration of AI and machine learning in enhancing imaging analysis, improving diagnostic accuracy, and optimizing treatment planning.
The journal has identified several emerging themes that reflect the current trends in nuclear medicine and molecular imaging. These themes indicate a growing interest in innovative technologies and their applications in clinical settings.
  1. AI and Deep Learning in Imaging:
    The integration of artificial intelligence and deep learning techniques is increasingly prevalent in imaging analysis, enhancing diagnostic accuracy and workflow efficiency.
  2. Personalized Medicine and Dosimetry:
    There is a rising focus on personalized dosimetry approaches, which optimize treatment based on individual patient characteristics and tumor biology, particularly in radioligand therapy.
  3. Innovative Radiopharmaceuticals:
    Research on novel radiopharmaceuticals, especially those targeting specific biomarkers in tumors, is gaining momentum, highlighting advancements in theranostics.
  4. Total-body Imaging Technology:
    The development and application of total-body PET imaging technology are emerging as a significant trend, with studies exploring its advantages in various clinical scenarios.
  5. Patient-Centric Approaches in Nuclear Medicine:
    An increasing number of studies are focusing on patient experience and outcomes, emphasizing the importance of integrating patient perspectives in nuclear medicine practice.

Declining or Waning

While the journal continues to address a wide range of topics in nuclear medicine and molecular imaging, some areas of research have shown a decline in publication frequency. This trend may reflect shifts in research focus or advancements in technology that render certain topics less relevant.
  1. Traditional Imaging Techniques:
    There has been a noticeable decrease in studies focused solely on conventional imaging techniques, such as planar scintigraphy, as newer hybrid and molecular imaging methods gain prominence.
  2. Basic Science Research in Radiopharmaceuticals:
    Research articles centered on basic science aspects of radiopharmaceuticals, such as preclinical studies without direct clinical application, have seen reduced publication frequency in favor of more clinically oriented studies.
  3. Non-targeted Radiopharmaceutical Applications:
    The journal has published fewer articles related to the non-targeted applications of radiopharmaceuticals, indicating a shift towards targeted therapies and precision medicine.

Similar Journals

Radiology-Imaging Cancer

Exploring New Frontiers in Cancer Imaging Techniques.
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-616XFrequency: 6 issues/year

Radiology-Imaging Cancer is a prestigious journal published by the Radiological Society of North America (RSNA), focusing on the critical intersection of radiology, oncology, and advanced imaging techniques. This journal stands out in its field with a commendable ranking in the Q2 category for Medicine (miscellaneous) and Oncology, and an impressive Q1 ranking in Radiology, Nuclear Medicine and Imaging, according to the 2023 quartiles. With an ISSN of 2638-616X, it serves as an essential platform for the dissemination of research that contributes to the understanding and improvement of cancer diagnosis and treatment. Its comprehensive scope encompasses a range of topics, from innovative imaging modalities to clinical applications in oncology, making it a valuable resource for researchers, clinicians, and students interested in the evolving field of cancer imaging. Despite being published in the United States, the journal aims for a global reach, catering to a wide audience dedicated to advancing medical science.

Molecular Imaging and Radionuclide Therapy

Advancing breakthroughs in molecular imaging and therapy.
Publisher: GALENOS PUBL HOUSEISSN: 2146-1414Frequency: 3 issues/year

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

Nuclear Medicine and Molecular Imaging

Unveiling Breakthroughs in Nuclear Medicine Research
Publisher: SPRINGER HEIDELBERGISSN: 1869-3474Frequency: 4 issues/year

Nuclear Medicine and Molecular Imaging, published by SPRINGER HEIDELBERG, stands as a pivotal platform in the interdisciplinary field of radiology and nuclear medicine, focusing on innovative research and developments from 2010 to 2024. With its ISSN 1869-3474 and E-ISSN 1869-3482, this journal aims to disseminate advanced studies that explore the diagnostic and therapeutic applications of nuclear medicine technologies. Operating from Germany, it has positioned itself in the Q3 category within the Radiology, Nuclear Medicine and Imaging sector, showcasing its relevance among peer journals, with a Scopus rank of #204 out of 333. This journal not only serves as an essential resource for researchers and practitioners eager to stay abreast of modern methodologies and findings but also underscores the crucial advancements in molecular imaging techniques. Although currently not an open-access journal, it doesn't detract from its mission to promote knowledge exchange among academia and the medical community, thus paving the way for innovative solutions and improved patient care in nuclear medicine.

BRITISH JOURNAL OF RADIOLOGY

Shaping the Future of Imaging through Rigorous Research
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

Hellenic Journal of Nuclear Medicine

Innovating the Future of Imaging and Radiology
Publisher: HELLENIC SOC NUCLEAR MEDICINEISSN: 1108-1430Frequency: 3 issues/year

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

Clinical Imaging

Advancing the Future of Diagnostic Imaging
Publisher: ELSEVIER SCIENCE INCISSN: 0899-7071Frequency: 6 issues/year

Clinical Imaging, published by Elsevier Science Inc, is a renowned journal dedicated to the field of radiology, nuclear medicine, and imaging. With an ISSN of 0899-7071 and an E-ISSN of 1873-4499, this esteemed publication has established its significance in advancing imaging science since its inception in 1989 and continues to make impactful contributions to the discipline through 2024. The journal holds a prestigious Q2 ranking in the category of Radiology, Nuclear Medicine, and Imaging, reflecting its critical role in bridging research and clinical practice. Currently ranked #113 out of 333 by Scopus, with a notable 66th percentile, it offers a platform for disseminating high-quality research, reviews, and case studies that inspire innovation and enhance imaging techniques. Although it primarily functions as a subscription-based journal, it remains dedicated to accessibility and the dissemination of pivotal findings that inform both academia and clinical settings. Clinical Imaging is essential for researchers, professionals, and students alike, offering insights that shape the future of diagnostic imaging.

EJNMMI Research

Empowering Research, Transforming Radiology.
Publisher: SPRINGERISSN: 2191-219XFrequency: 1 issue/year

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

American Journal of Nuclear Medicine and Molecular Imaging

Illuminating the Path of Nuclear Medicine Discoveries
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

AMERICAN JOURNAL OF ROENTGENOLOGY

Innovating Medical Imaging Practices.
Publisher: AMER ROENTGEN RAY SOCISSN: 0361-803XFrequency: 12 issues/year

AMERICAN JOURNAL OF ROENTGENOLOGY (AJR), published by the American Roentgen Ray Society, stands as a beacon of excellence in the fields of Radiology, Nuclear Medicine, and Imaging. With an impressive impact factor positioning it in the Q1 category of both Medicine (Miscellaneous) and Radiology as of 2023, AJR is ranked 13th out of 333 journals in its category, reflecting its prominent presence and high relevance in advancing medical imaging knowledge and practice. Established in 1973 and continuing through to 2024, the journal encompasses a broad spectrum of research, critical reviews, and innovative techniques, making it a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access options, AJR ensures that its rigorous, peer-reviewed content remains accessible to a global audience committed to the evolution of radiological science. With its home base in Leesburg, Virginia, AJR not only informs but also inspires advancements in radiology, enhancing diagnostic practices and patient care globally.

NUCLEAR MEDICINE AND BIOLOGY

Elevating standards in nuclear medicine and biological research.
Publisher: ELSEVIER SCIENCE INCISSN: 0969-8051Frequency: 8 issues/year

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.